Skip to content

Evaluation of abnormal body movements and heart rate variability during Sevoflurane (for induction and maintenance of anaesthesia) induction in children - An observational (no intervention) study

Evaluation of abnormal body movements and heart rate variability during Sevoflurane induction in children - An observational study

Status
Recruiting
Phases
Phase 3Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/05/033906
Enrollment
500
Registered
2021-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H523- Anisometropia and aniseikonia Health Condition 2: H570- Anomalies of pupillary function Health Condition 3: H532- Diplopia Health Condition 4: H049- Disorder of lacrimal system, unspecified Health Condition 5: H260- Infantile and juvenile cataract Health Condition 6: H402- Primary angle-closure glaucoma Health Condition 7: H330- Retinal detachment with retinal break Health Condition 8: H179- Unspecified corneal scar and opacity Health Condition 9: H431- Vitreous hemorrh

Interventions

None listed

Sponsors

AIIMS New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children undergoing elective ophthalmic surgery during the study period

Exclusion criteria

Exclusion criteria: 12 years

Design outcomes

Primary

MeasureTime frame
Incidence of abnormal body movements with Sevoflurane at the time of induction in childrenTimepoint: Incidence of abnormal body movements with Sevoflurane at time of induction in children

Secondary

MeasureTime frame
Assess need for treatment due to side effects of SevofluraneTimepoint: At induction of anaesthesia;Incidence of heart rate variability during inductionTimepoint: At induction

Countries

India

Contacts

Public ContactRenu Sinha

AIIMS ( New Delhi)

renusinhaagarwal@gmail.com9810305156

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026